Dirk Arnold, MD, PhD, Asklepios Tumorzentrum Hamburg, Hamburg, Germany, describes useful types of data and information that should be included in gastrointestinal cancer registries. Tumor and patient characteristics are vital for clinicians, and tumor biology has additionally been identified as useful data points to collect. Dr Arnold also highlights the potential utility of imaging and biomaterials in registries. This interview took place at the ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.